Primary treatment and survival in malignant ovarian germ cell tumors: A nationwide population-based Swedish Gynecologic Cancer Group (SweGCG) study
MOGCTs had excellent survival outcomes in this nationwide population-based study, and fertility-sparing surgery was deemed safe. Future efforts should focus on improving outcomes in older women and those with stage IV disease.
Authors
- Camilla Sköld (ORCID: https://orcid.org/0000-0001-8212-0003)
- Karin Stålberg (ORCID: https://orcid.org/0000-0001-5527-8796)
- Preben Kjølhede (ORCID: https://orcid.org/0000-0001-5702-4116)
- Kristina Hellman (ORCID: https://orcid.org/0000-0002-5124-7412)
- Maria Bjurberg (ORCID: https://orcid.org/0000-0001-5315-4423)
- Angelique Flöter Rådestad (ORCID: https://orcid.org/0000-0002-1068-9732)
- Pernilla Dahm Kähler
- Christer Borgfeldt (ORCID: https://orcid.org/0000-0003-2267-8325)
- Katja Stenström Bohlin (ORCID: https://orcid.org/0000-0002-9064-8454)
- Jenny-Maria Jönsson (ORCID: https://orcid.org/0000-0002-6208-7813)
- Erik Holmberg (ORCID: https://orcid.org/0000-0001-5107-4550)
- Cecilia Olsson (ORCID: https://orcid.org/0000-0002-0944-5650)
- Elisabeth Åvall Lundqvist
Institutions
- Linköping University (SE)
- Uppsala University (SE)
- Karolinska University Hospital (SE)
- Lund University (SE)
- Karolinska Institutet (SE)
- Lovisenberg Diakonale Høgskole (NO)
- Skåne University Hospital (SE)
- University of Gothenburg (SE)
Publication Details
- Journal
- Gynecologic Oncology
- Published
- 2025-10-29
- DOI
- https://doi.org/10.1016/j.ygyno.2025.10.019
- Primary Topic
- Testicular diseases and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00